rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1

by Montefiori DC, Huang Y, Karuna S, Allen M, Kochar N, Chappuis S, Gaillard J, Tomaras G, Graham B, Bart P, Pantaleo G
Published 2012-09-01

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies

by Fuchs JD, Morgan C, Bart P, Kochar N, Frahm N, Swann E, Gilbert P, DeRosa S, Graham B, Nabel G, Liao H, Haynes B, Tomaras G
Published 2012-09-01

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting

by Spearman P, Tomaras G, Montefiori D, Huang Y, Ahmed H, Elizaga M, Hural J, McElrath J, Ouedraogo L, Pensiero M, Butler C, Kalams S, Overton ET, Barnett S, Group N
Published 2012-09-01

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers

by Caskey M, Trumpfheller C, Pollak S, Sinnenberg L, Hurley A, Pring J, Shimeliovich I, Yipp B, Anandasabapathy N, Mehandru S, Sarma P, Koup R, Bailer R, Tomaras G, Sato A, Keler T, Steinman R, Schlesinger S
Published 2012-09-01

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

by Goepfert P, Elizaga M, Montefiori D, Hural J, DeRosa S, Tomaras G, Seaton K, Sato A, Ouedraogo L, Donastorg Y, Cardinali M, Lama J, Baden L, Keefer M, McElrath J, Kalams S, Robinson H
Published 2012-09-01

P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI)

by Denny T, Markowitz M, Shaw G, Margolis D, Shea T, Gao F, Yang Y, Amos J, Marshall D, Whitesides J, Mcparland M, Parks R, Derosa K, Foulger A, Nagel A, Zhang R, Moody M, Munshaw S, Dixon A, Chen X, Liao L, Kelsoe G, Tomaras G, Kepler T, Haynes B
Published 2009-10-01

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

by Pollara J, Bonsignori M, Moody M, Alam M, Liao H, Hwang K, Pickeral J, Kappes J, Ochsenbauer C, Soderberg K, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Montefiori D, Robinson JE, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim J, Michael N, Tomaras G, Haynes BF, Ferrari G
Published 2012-09-01

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel

by Archary, D, Seaton, K E, Passmore, J S, Werner, L, Deal, A, Yates, N L, Bergin, P, Liebenberg, L J, Samsunder, N, Mureithi, M W, Altfeld, M, Garrett, N, Abdool Karim, Q, Abdool Karim, S S, Morris, L, Tomaras, G D, Dunphy, Laura J., Arnold, Kelly Benedict, Lauffenburger, Douglas A
Published 2017

Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies

by Ma, Ben-Jiang, Alam, S. Munir, Go, Eden P., Lu, Xiaozhi, Desaire, Heather, Tomaras, Georgia D., Bowman, Cindy, Sutherland, Laura L., Scearce, Richard M., Santra, Sampa, Letivn, Norman L., Kepler, Thomas B., Liao, Hua-Xin, Haynes, Barton F.
Published 2011